Focused on tomorrow to deliver better cancer care today

At OncocyteTM, we believe that empowering physicians with bold and innovative diagnostic solutions may lead to better outcomes for their patients.


Doctors and Patients

Unfortunately, cancer is a leading cause of death in the United States. Each and every year, employers, insurance companies, taxpayer-funded programs, and patients and their families spend more than 150 billion dollars on cancer-related health care.1 Yet despite the availability of more advanced screening methods and treatments, we are still fighting a losing battle. This is particularly true for lung cancer, for which survival rates have not significantly improved in more than 50 years.2

We imagine a better future.

Oncocyte is a molecular diagnostics company with a mission to provide actionable answers to physicians and patients at critical decision points across the cancer care continuum. Our goal is to provide tests and solutions that may help diagnosis and treatment, leading to improved patient outcomes and reducing the overall cost of care.

Our Team


Oncocyte’s leadership team has extensive experience in molecular diagnostics and is dedicated to advancing the continuum of care in lung cancer.

Ronald Andrews

President & CEO

Mitch Levine

Chief Financial Officer

Doug Ross M.D., Ph.D.

Chief Science Officer

Padma Sundar

Chief Commercial Officer

We believe

in the power of possibilites. Do you?

We are looking for dedicated individuals to help us bring innovative solutions to physicians and patients.

Please send us your resume to if you would like to be part of this growing and dynamic team.

Meet Our

Scientific and Medical Advisors

David Gandara


Thomas Bauer


D. Kyle Hogarth


Edwar F. Patz Jr.




Oncocyte’s laboratory located in Brisbane, CA holds a CLIA Certificate of Accreditation from the Centers for Medicare & Medicaid Services (CMS). Our biopharma services laboratory in Nashville, TN is CLIA-certified and CAP-accredited. Oncocyte also holds clinical laboratory licenses from California and 48 other U.S. states.



Contact Us


1. National Cancer Institute. Cancer Prevalence and Cost of Care Projections. Accessed October 17, 2019 from

2. American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society; 2017.